Barclays PLC Liva Nova PLC Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Liva Nova PLC stock. As of the latest transaction made, Barclays PLC holds 1,357,196 shares of LIVN stock, worth $74.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,357,196

Previous 968,791 40.09%

Holding current value

$74.4 Million

Previous $50.1 Million 51.47%

% of portfolio

0.03%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$48.6 - $57.12 $18.9 Million - $22.2 Million	388,405 Added 40.09%	1,357,196 $75.9 Million
Q4 2023 Feb 15, 2024	BUY	$43.45 - $53.66 $5.08 Million - $6.27 Million	116,921 Added 13.73%	968,791 $50.1 Million
Q3 2023 Nov 07, 2023	BUY	$50.12 - $58.87 $5.86 Million - $6.88 Million	116,842 Added 15.9%	851,870 $45 Million
Q2 2023 Aug 03, 2023	BUY	$42.28 - $51.43 $2.88 Million - $3.5 Million	68,100 Added 10.21%	735,028 $37.8 Million
Q1 2023 May 04, 2023	BUY	$40.84 - $58.14 $8.79 Million - $12.5 Million	215,304 Added 47.67%	666,928 $29.1 Million

Q4 2022 Feb 13, 2023	SELL	$43.88 - $56.16 $11.1 Million - $14.3 Million	-253,948 Reduced 35.99%	451,624 $25.1 Million
Q3 2022 Nov 03, 2022	BUY	$48.37 - $66.5 $8.9 Million - $12.2 Million	184,009 Added 35.28%	705,572 $35.8 Million
Q2 2022 Aug 12, 2022	BUY	$57.25 - $86.63 $3.71 Million - $5.61 Million	64,800 Added 14.19%	521,563 $32.6 Million
Q1 2022 May 16, 2022	SELL	$71.02 - $86.99 $511,130 - $626,067	-7,197 Reduced 1.55%	456,763 $37.4 Million
Q4 2021 Feb 14, 2022	BUY	$76.72 - $92.68 $2.44 Million - $2.95 Million	31,857 Added 7.37%	463,960 $40.6 Million
Q3 2021 Nov 09, 2021	SELL	$76.02 - $88.62 $1.23 Million - $1.44 Million	-16,228 Reduced 3.62%	432,103 $34.2 Million
Q2 2021 Aug 13, 2021	SELL	$73.44 - $87.01 $2.38 Million - $2.82 Million	-32,443 Reduced 6.75%	448,331 $37.7 Million
Q1 2021 May 13, 2021	SELL	$62.9 - $82.41 $261,915 - $343,155	-4,164 Reduced 0.86%	480,774 $35.4 Million
Q4 2020 Feb 11, 2021	SELL	$46.01 - $68.74 $1.35 Million - $2.01 Million	-29,268 Reduced 5.69%	484,938 $32.1 Million
Q3 2020 Nov 12, 2020	SELL	$41.91 - $57.81 $28 Million - $38.6 Million	-668,388 Reduced 56.52%	514,206 $23.2 Million
Q2 2020 Aug 12, 2020	BUY	$39.87 - $56.9 $45.5 Million - $64.9 Million	1,140,317 Added 2697.25%	1,182,594 $56.9 Million
Q1 2020 May 13, 2020	SELL	$34.22 - $76.49 $588,960 - $1.32 Million	-17,211 Reduced 28.93%	42,277 $1.91 Million
Q4 2019 Feb 10, 2020	BUY	$68.92 - $85.27 $1.98 Million - $2.45 Million	28,690 Added 93.16%	59,488 $4.49 Million
Q3 2019 Nov 14, 2019	SELL	$71.74 - $86.35 $798,394 - $960,989	-11,129 Reduced 26.54%	30,798 $2.27 Million
Q2 2019 Aug 14, 2019	BUY	$66.45 - $97.36 $1.24 Million - $1.81 Million	18,635 Added 80.01%	41,927 $3.02 Million
Q1 2019 May 15, 2019	BUY	$86.15 - $100.49 $1.21 Million - $1.41 Million	14,045 Added 151.89%	23,292 $2.27 Million
Q4 2018 Feb 14, 2019	SELL	$84.14 - $125.42 $2.86 Million - $4.26 Million	-33,939 Reduced 78.59%	9,247 $845,000
Q3 2018 Nov 14, 2018	SELL	$101.02 - $130.95 $4.91 Million - $6.36 Million	-48,587 Reduced 52.94%	43,186 $5.36 Million
Q2 2018 Aug 14, 2018	BUY	$81.75 - $105.37 $2.61 Million - $3.37 Million	31,944 Added 53.39%	91,773 $9.16 Million
Q1 2018 May 15, 2018	BUY	$79.95 - $89.74 $1.7 Million - $1.91 Million	21,232 Added 55.01%	59,829 $5.3 Million
Q4 2017 Feb 14, 2018	SELL	$71.8 - $88.21 $171,243 - $210,380	-2,385 Reduced 5.82%	38,597 $3.08 Million
Q3 2017 Nov 14, 2017	BUY	$60.32 - $70.06 $2.47 Million - $2.87 Million	40,982	40,982 $2.87 Million

Others Institutions Holding LIVN

# of Institutions

252

Shares Held

56.2M

Call Options Held

367K

Put Options Held

597K

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.94B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account